Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research conducted at K.A. Metcalfe and co-authors has provided new information about breast cancer
May 12th, 2008
According to a study from Toronto, Canada, " To evaluate the rate of prophylactic contralateral mastectomy in an international cohort of women with hereditary breast cancer and to evaluate the predictors of uptake of preventive surgery. Patients and Methods Women with a BRCA1 or BRCA2 mutation who had been diagnosed with unilateral breast cancer were followed prospectively for a minimum of 1.5 years." "Information was collected on prophylactic surgery, tamoxifen use, and the occurrence of contralateral breast cancer. Nine hundred twenty-seven women were included in the study; of these, 253 women (27.3%) underwent a contralateral prophylactic mastectomy after the...
Source: Biotech Business Week (2008-05-12)
|
